Suchergebnisse - "van de Loosdrecht, Arjan A"

PubPharm (257)

1

Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia

enthalten in: Leukemia | 2024

von Tettero, J. | Heidinga, M. | Mocking, T. | +11

2

Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells

enthalten in: Leukemia | 2024

von van Spronsen, M. | Van Gassen, S. | Duetz, C. | +3

3

Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML

enthalten in: HemaSphere | 2023

von Tettero, J. | Buisman, Y. | Ngai, L. | +10

4

Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001

enthalten in: HemaSphere | 2023

von Janssen, L. | Westers, T. | Rovers, J. | +4

5

ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non-myeloablative conditioning

enthalten in: British journal of haematology | 2023

von Aydin, M. | de Leeuw, D. | Rutten, C. | +9

6

Challenging the status flow : how artificial intelligence is advancing diagnosis of myelodysplastic neoplasms

enthalten in: Haematologica | 2023

von Duetz, C. | Westers, T. | Van de Loosdrecht, A.

CommentOn: Haematologica. 2023 Sep 01;108(9):2435-2443. - PMID 36924240

7

Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome : Real-world data from a multicenter cohort study

enthalten in: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine | 2023

von de Roij van Zuijdewijn, C. | Westerweel, P. | Schipperus, M. | +3

8

Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine

enthalten in: Blood cancer journal | 2023

von Hilberink, J. | van Zeventer, I. | Chitu, D. | +54

9

Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial

enthalten in: Blood | 2023

von Ngai, L. | Hanekamp, D. | Janssen, F. | +27

10

Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes

enthalten in: Blood | 2023

von Zeidan, A. | Platzbecker, U. | Bewersdorf, J. | +33

CommentIn: Blood. 2023 Apr 27;141(17):2035-2036. - PMID 37103953

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]